Welcome to Public Health On Call, a new podcast from the Johns Hopkins Bloomberg School of Public Health.

Our focus is the novel coronavirus.

I'm Josh Sharfstein, a faculty member at Johns Hopkins, and also a former secretary of Maryland's health department.

Our goal with this podcast is to bring evidence and experts to help you understand today's

news about the novel coronavirus and what it means for tomorrow.

If you have questions, you can email them to public health question at jhh.edu.

That's public health question at jh.hu.edu for future podcast episodes.

Today, Stephanie Desmond speaks to Deney Wirtz and Julie Mezersmith, two people coordinating

all of the COVID-19 research at Johns Hopkins, and there is lots being done.

They discuss not only the new innovations

being explored to help patients and health care workers, but also what the pandemic means

for other kinds of research that have been virtually shut down. Let's listen. Thanks for joining

me. Thank you for having us. So, Denise, please tell me a little bit about what Hopkins

has undertaken in light of this pandemic, which seems to keep spreading.

Indeed.

And in a way, it started off some four weeks ago, which

feels like months ago, in the wake of our public health

especially is telling us it was time to really seriously think about

winding down, ramping down all such operations and start really be consistent in our actions.

We'd ask undergraduate students to leave the campus. It was right around a spring break,

and it was only fair with be consistent

in asking of fellows or postdocs or students or faculty

...